Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Upstream Bio gains FDA alignment for pivotal verekitug trials across asthma and nasal polyps Upstream Bio sets Phase 3 plans for quarterly verekitug in severe asthma and CRSwNP. See what FDA alignment means for the biotech’s growth strategy. bySoujanya RaviSeptember 3, 2026